SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indo Us Bio-Tech informs about clarification

21 Jun 2024 Evaluate

Indo Us Bio-Tech has informed regarding error in standalone financial results for the quarter and half year ended 30th September, 2023.

The above information is a part of company’s filings submitted to BSE.

Indo US Bio-Tech Share Price

85.92 -0.52 (-0.60%)
10-Jul-2026 13:09 View Price Chart
Peers
Company Name CMP
Venkys (India) 1423.25
Mangalam Global Ent. 16.95
Kaveri Seed 868.70
Regaal Resources 80.60
Simran Farms 154.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: